Telos Capital Management Inc. Sells 3,780 Shares of Danaher Corporation $DHR

Telos Capital Management Inc. reduced its stake in Danaher Corporation (NYSE:DHR) by 7.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 43,772 shares of the conglomerate’s stock after selling 3,780 shares during the quarter. Telos Capital Management Inc.’s holdings in Danaher were worth $9,698,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of DHR. BlackRock Inc. bought a new position in shares of Danaher during the second quarter worth approximately $10,492,520,000. Wellington Management Group LLP lifted its holdings in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after purchasing an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC bought a new stake in Danaher in the 2nd quarter valued at $1,456,317,000. Generation Investment Management LLP bought a new stake in shares of Danaher in the second quarter valued at about $1,287,949,000. Finally, Bank of America Corp DE bought a new stake in Danaher in the 2nd quarter valued at about $993,846,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In other Danaher news, CAO Christopher Bouda sold 7,598 shares of the business’s stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.80% of the stock is owned by company insiders.

Danaher Trading Down 3.6%

Shares of Danaher stock opened at $226.43 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a market capitalization of $159.30 billion, a price-to-earnings ratio of 37.06, a PEG ratio of 2.95 and a beta of 0.76. The firm’s 50-day moving average price is $219.98 and its two-hundred day moving average price is $201.62.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.89 EPS. On average, analysts forecast that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is 26.19%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of analyst reports. The Goldman Sachs Group reiterated a “buy” rating and issued a $275.00 price target on shares of Danaher in a research report on Thursday, October 22nd. Barclays boosted their price target on Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. DZ Bank downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Guggenheim raised their price objective on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. Finally, Royal Bank Of Canada lifted their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $242.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.